Chancellor Rachel Reeves Plans Targeted Action on Living Costs in Forthcoming Budget

Chancellor Reeves has stated she is planning "specific action to deal with cost of living challenges" in the forthcoming Budget.

In comments to the BBC, she stated that lowering price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven advanced economies this year and the following year.

Possible Energy Bill Interventions

It is understood the administration could intervene to bring down utility costs, for example by cutting the present 5% level of value-added tax applied on energy supplies.

A further possibility is to lower some of the regulatory levies presently added to household expenses.

Budgetary Constraints and Expert Expectations

The administration will obtain the latest assessment from the official forecaster, the OBR, on Monday, which will show how much room there is for such actions.

The consensus from most analysts is that Reeves will have to declare tax rises or spending cuts in order to fulfill her self-imposed debt limits.

Earlier on the same day, estimates suggested there was a twenty-two billion pound deficit for the Treasury chief to resolve, which is at the lower end of projections.

"It is a shared responsibility between the central bank and the administration to further reduce some of the drivers of price increases," Reeves stated to reporters in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While much of the attention has been on likely tax rises, the Treasury chief said the latest figures from the OBR had not changed her vow to election pledges not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "uncertain world" with rising geopolitical and commercial issues for the Budget revenue measures, likely to be focused on those "most able to pay."

International Trade Tensions

Commenting on worries about the UK's trade ties with the Asian nation she said: "The UK's national security always come first."

Recent announcement by Chinese authorities to increase trade restrictions on rare earths and other resources that are key for high-technology manufacturing led US President Donald Trump to threaten an further 100% tariff on goods from China, raising the prospect of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a international production power grab."

Questioned on accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the world economy and generates additional headwinds."

"In my view there are fields where we need to address Chinese policies, but there are also valuable opportunities to export to Chinese markets, including financial services and other areas of the economic system. We've got to get that balance right."

The Treasury chief also confirmed she was collaborating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also recognized that the price the NHS spends on drugs could increase as a consequence of ongoing talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling operations in the UK, with several blaming the insufficient payments they are getting.

Recently, the government science advisor said the price the NHS pays for medicines would need to rise to halt businesses and drug research funding departing from the United Kingdom.

The Chancellor told media: "We have seen due to the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the UK in the extent that they are in other continental states."

"Our aim is to make sure that patients receiving care from the NHS are able to obtain the best critical treatments in the globe. And so we are looking at this situation, and... aiming to attract increased capital into Britain."

Jessica Thomas
Jessica Thomas

A tech enthusiast and writer passionate about innovation and self-improvement, sharing insights from years of experience.